0
0.5
1
1.5
2+
Mortality
-5%
Improvement
Relative Risk
ICU admission
-9%
Hospitalization
-36%
Recovery
-2%
post-hoc primary
Recovery, cough
13%
Recovery, tachypnea
17%
Viral clearance
-23%
Ivermectin Rezai et al. EARLY TREATMENT DB RCT
Is early treatment with ivermectin beneficial for COVID-19?
Double-blind RCT 549 patients in Iran (February - August 2021)
Multiple critical issues, see analysis
c19ivm.org
Rezai et al., Frontiers in Medicine, Jun 2022
Favors ivermectin
Favors control